Global Influenza Vaccine Market Research Report 2021

Publisher Name :
Date: 22-Feb-2021
No. of pages: 91
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Whole Virus Vaccines

- Split Virus Vaccines

- Subunit Vaccines

- Live Attenuated Virus Vaccines

Segment by Application

- For Children (6 months to 3 years)

- For Adults and Children over 3 years

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- CSL

- GSK

- Sanofi Pasteur

- Mylan

- AstraZeneca

- Pfizer

- Johnson & Johnson

Global Influenza Vaccine Market Research Report 2021

Table of Contents
1 Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Influenza Vaccine
1.2 Influenza Vaccine Segment by Type
1.2.1 Global Influenza Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Whole Virus Vaccines
1.2.3 Split Virus Vaccines
1.2.4 Subunit Vaccines
1.2.5 Live Attenuated Virus Vaccines
1.3 Influenza Vaccine Segment by Application
1.3.1 Influenza Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Global Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Influenza Vaccine Revenue 2016-2027
1.4.2 Global Influenza Vaccine Sales 2016-2027
1.4.3 Influenza Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Influenza Vaccine Market Competition by Manufacturers
2.1 Global Influenza Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Influenza Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Influenza Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Influenza Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Influenza Vaccine Players Market Share by Revenue
2.5.3 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Influenza Vaccine Market Facts & Figures by Country
3.3.1 North America Influenza Vaccine Sales by Country
3.3.2 North America Influenza Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Influenza Vaccine Market Facts & Figures by Country
3.4.1 Europe Influenza Vaccine Sales by Country
3.4.2 Europe Influenza Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Influenza Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Influenza Vaccine Sales by Region
3.5.2 Asia Pacific Influenza Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Influenza Vaccine Market Facts & Figures by Country
3.6.1 Latin America Influenza Vaccine Sales by Country
3.6.2 Latin America Influenza Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Influenza Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Influenza Vaccine Sales by Country
3.7.2 Middle East and Africa Influenza Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Influenza Vaccine Historic Market Analysis by Type
4.1 Global Influenza Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Influenza Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Influenza Vaccine Price by Type (2016-2021)
5 Global Influenza Vaccine Historic Market Analysis by Application
5.1 Global Influenza Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Influenza Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Influenza Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CSL Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Corporation Information
6.3.2 Sanofi Pasteur Description and Business Overview
6.3.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Pasteur Product Portfolio
6.3.5 Sanofi Pasteur Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 AstraZeneca Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Pfizer Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Johnson & Johnson Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
7 Influenza Vaccine Manufacturing Cost Analysis
7.1 Influenza Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Influenza Vaccine
7.4 Influenza Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Influenza Vaccine Distributors List
8.3 Influenza Vaccine Customers
9 Influenza Vaccine Market Dynamics
9.1 Influenza Vaccine Industry Trends
9.2 Influenza Vaccine Growth Drivers
9.3 Influenza Vaccine Market Challenges
9.4 Influenza Vaccine Market Restraints
10 Global Market Forecast
10.1 Influenza Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Influenza Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Influenza Vaccine by Type (2022-2027)
10.2 Influenza Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Influenza Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Influenza Vaccine by Application (2022-2027)
10.3 Influenza Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Influenza Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Influenza Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Influenza Vaccine Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Influenza Vaccine Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global Influenza Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Influenza Vaccine Covered in This Study
Table 5. Global Influenza Vaccine Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Influenza Vaccine Sales Share by Manufacturers (2016-2021)
Table 7. Global Influenza Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Influenza Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Influenza Vaccine Average Price (USD/Doses) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Influenza Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Influenza Vaccine Product Type
Table 12. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Influenza Vaccine Sales by Region (2016-2021) & (K Doses)
Table 16. Global Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 19. North America Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Influenza Vaccine Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Influenza Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Influenza Vaccine Sales (K Doses) by Type (2016-2021)
Table 39. Global Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Influenza Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Influenza Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Influenza Vaccine Price (USD/Doses) by Type (2016-2021)
Table 43. Global Influenza Vaccine Sales (K Doses) by Application (2016-2021)
Table 44. Global Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Influenza Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Influenza Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Influenza Vaccine Price (USD/Doses) by Application (2016-2021)
Table 48. CSL Corporation Information
Table 49. CSL Description and Business Overview
Table 50. CSL Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 51. CSL Influenza Vaccine Product
Table 52. CSL Recent Developments/Updates
Table 53. GSK Corporation Information
Table 54. GSK Description and Business Overview
Table 55. GSK Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 56. GSK Influenza Vaccine Product
Table 57. GSK Recent Developments/Updates
Table 58. Sanofi Pasteur Corporation Information
Table 59. Sanofi Pasteur Description and Business Overview
Table 60. Sanofi Pasteur Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 61. Sanofi Pasteur Influenza Vaccine Product
Table 62. Sanofi Pasteur Recent Developments/Updates
Table 63. Mylan Corporation Information
Table 64. Mylan Description and Business Overview
Table 65. Mylan Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 66. Mylan Influenza Vaccine Product
Table 67. Mylan Recent Developments/Updates
Table 68. AstraZeneca Corporation Information
Table 69. AstraZeneca Description and Business Overview
Table 70. AstraZeneca Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 71. AstraZeneca Influenza Vaccine Product
Table 72. AstraZeneca Recent Developments/Updates
Table 73. Pfizer Corporation Information
Table 74. Pfizer Description and Business Overview
Table 75. Pfizer Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 76. Pfizer Influenza Vaccine Product
Table 77. Pfizer Recent Developments/Updates
Table 78. Johnson & Johnson Corporation Information
Table 79. Johnson & Johnson Description and Business Overview
Table 80. Johnson & Johnson Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 81. Johnson & Johnson Influenza Vaccine Product
Table 82. Johnson & Johnson Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Influenza Vaccine Distributors List
Table 86. Influenza Vaccine Customers List
Table 87. Influenza Vaccine Market Trends
Table 88. Influenza Vaccine Growth Drivers
Table 89. Influenza Vaccine Market Restraints
Table 90. Global Influenza Vaccine Sales Forecast by Type (2022-2027) & (K Doses)
Table 91. Global Influenza Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Influenza Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Influenza Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Influenza Vaccine Sales Forecast by Application (2022-2027) & (K Doses)
Table 95. Global Influenza Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Influenza Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Influenza Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Influenza Vaccine Sales Forecast by Region (2022-2027) & (K Doses)
Table 99. Global Influenza Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Influenza Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Influenza Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Influenza Vaccine
Figure 2. Global Influenza Vaccine Market Share by Type in 2020 & 2027
Figure 3. Whole Virus Vaccines Product Picture
Figure 4. Split Virus Vaccines Product Picture
Figure 5. Subunit Vaccines Product Picture
Figure 6. Live Attenuated Virus Vaccines Product Picture
Figure 7. Global Influenza Vaccine Market Share by Application in 2020 & 2027
Figure 8. For Children (6 months to 3 years)
Figure 9. For Adults and Children over 3 years
Figure 10. Global Influenza Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Influenza Vaccine Market Size 2016-2027 (US$ Million)
Figure 12. Global Influenza Vaccine Sales 2016-2027 (K Doses)
Figure 13. Global Influenza Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Influenza Vaccine Sales Share by Manufacturers in 2020
Figure 15. Global Influenza Vaccine Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Influenza Vaccine Players: Market Share by Revenue in 2020
Figure 17. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Influenza Vaccine Sales Market Share by Region (2016-2021)
Figure 19. Global Influenza Vaccine Sales Market Share by Region in 2020
Figure 20. Global Influenza Vaccine Revenue Market Share by Region (2016-2021)
Figure 21. Global Influenza Vaccine Revenue Market Share by Region in 2020
Figure 22. U.S. Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Influenza Vaccine by Type (2016-2021)
Figure 47. Sales Market Share of Influenza Vaccine by Application (2016-2021)
Figure 48. Sales Market Share of Influenza Vaccine by Application in 2020
Figure 49. Revenue Share of Influenza Vaccine by Application (2016-2021)
Figure 50. Revenue Share of Influenza Vaccine by Application in 2020
Figure 51. Manufacturing Cost Structure of Influenza Vaccine
Figure 52. Manufacturing Process Analysis of Influenza Vaccine
Figure 53. Influenza Vaccine Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
  • Global Avian Influenza Vaccines Sales Market Report 2021
    Published: 06-Apr-2021        Price: US 4000 Onwards        Pages: 139
    The global Avian Influenza Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Avian Influenza Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Type H5 - Type H9 - ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Report 2021
    Published: 01-Apr-2021        Price: US 4000 Onwards        Pages: 134
    The global 23-Valent Pneumococcal Polysaccharide Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global 23-Valent Pneumococcal Polysaccharide Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type......
  • Global Covid-19 Vaccine Market - Analysis By Product Type, Patient Type, End User, By Region, By Country (2021 Edition): Market Insights, Competition and Forecast (2020-2030)
    Published: 31-Mar-2021        Price: US 2000 Onwards        Pages: 214
    Executive Summary Global Covid-19 vaccine Market will be valued at approximately USD 25 billion in the year 2024. The growing government support for vaccine development and the increasing involvement of global organizations in the development of adequate vaccination facilities in endemic regions is anticipated to positively influence the sales of Coronavirus vaccine in the upcoming years. Moreover, the strong demand for coronavirus vaccine, the ongoing initiative initiatives by go......
  • 2020-2025 Global H1N1 Vaccines Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 30-Mar-2021        Price: US 3360 Onwards        Pages: 97
    This report elaborates the market size, market characteristics, and market growth of the H1N1 Vaccines industry, and breaks down according to the type, application, and consumption area of H1N1 Vaccines. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry re......
  • 2020-2025 Global Influenza Vaccine Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 25-Mar-2021        Price: US 3360 Onwards        Pages: 120
    Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... This report elaborates the market size, market characteristics, and market growth of the Influenza Vaccine industry, and breaks down according to the type, application, and consumption area of Influenza Vaccine. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chap......
  • Global Encephalitis Vaccination Market Growth (Status and Outlook) 2021-2026
    Published: 22-Mar-2021        Price: US 3660 Onwards        Pages: 115
    According to this latest study, the 2021 growth of Encephalitis Vaccination will have significant change from previous year. By the most conservative estimates of global Encephalitis Vaccination market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1196.1 million in 2020. Over the next five years the Encephalitis Vaccination market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 1499.2 million by 2026. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2021-2026
    Published: 19-Mar-2021        Price: US 3660 Onwards        Pages: 137
    According to this latest study, the 2021 growth of 23-Valent Pneumococcal Polysaccharide Vaccine will have significant change from previous year. By the most conservative estimates of global 23-Valent Pneumococcal Polysaccharide Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2326.5 million in 2020. Over the next five years the 23-Valent Pneumococcal Polysaccharide Vaccine market will register a 14.9% CAGR in terms of revenue, the g......
  • Global Encephalitis Vaccination Market Analysis 2016-2020 and Forecast 2021-2026
    Published: 18-Mar-2021        Price: US 2980 Onwards        Pages: 87
    Snapshot The global Encephalitis Vaccination market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Encephalitis Vaccination by product, region and application, in addition, this report introduces market competition situation among the vendor......
  • Global Avian Influenza Vaccines Market Growth 2021-2026
    Published: 18-Mar-2021        Price: US 3660 Onwards        Pages: 131
    According to this latest study, the 2021 growth of Avian Influenza Vaccines will have significant change from previous year. By the most conservative estimates of global Avian Influenza Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 109.1 million in 2020. Over the next five years the Avian Influenza Vaccines market will register a 2.5% CAGR in terms of revenue, the global market size will reach US$ 120.3 million by 2026. ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs